The stark images of a single home standing amid charred ruins of its neighbors are an apocalyptic memory of the Eaton and Palisades fires across Los Angeles in January 2025, 18 months ago. There was one house left standing in Malibu. Another in Altadena.
Thanks to a unique partnership with the Arlington Southwest Little League through CBS EcoMedia’s WellnessAd program, Chevrolet is supplying brand-new uniforms and athletic equipment for more than 2,000 youth athlete players enrolled with the Arlington Southwest Little League.
Today, Novartis announced the launch of Novartis Access in Kenya, the first country to benefit from a portfolio of 15 affordable medicines to treat cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. The Novartis portfolio is being offered to the Kenyan government, non-governmental organizations and other public-sector healthcare providers for USD 1 per treatment, per month.
We are all connected to a child with a life-threatening illness through six degrees or less. Whether you are impacted directly, or indirectly, these children touch our hearts with their immense bravery, strength and courage. Give Kids The World Village exists to ensure that these children and their families are given that extra bit of hope, happiness and love to confront the immense challenges of living with a life-threatening illness.
A $25 million grant from the James M. Cox Foundation will launch new patient-centered care models at Emory designed to improve patient experiences and outcomes. Prostate cancer care will be the initial clinical focus of the model.
The trend towards supply chain transparency is not only growing and evolving within areas already implementing regulations, but it is also expanding into new regions. While many in the European Union saw the good that the RoHS directive was doing, others around the world quickly began to take notice.
GSK today announced that it has submitted a regulatory application to the European Medicines Agency (EMA) for its antiseptic chlorhexidine gel (7.1% chlorhexidine digluconate gel, equivalent to 4% chlorhexidine) for the prevention of umbilical cord infections (omphalitis) in newborn babies. GSK’s work to develop the gel began in response to a call from the United Nations (UN) in 2012 for manufacturers to make a high quality chlorhexidine product suitable for newborn infants in low resources settings.
The SCS Kingfisher certification mark is showing up on an increasing number of products around the world. It differentiates companies that are making...
Join us as we travel the world to uncover real stories of impact—from landfills and energy transition to workplace safety, emerging contaminants, and...
The business landscape is reorienting itself and you can almost hear priorities shifting toward change-readiness and the bigger picture. And in this...
Position Action Against Hunger as a leading advocate for policy change and investment—calling for increased public health spending, improved nutrition...
Since 1950, Southwire has powered progress, from bringing light to rural communities to enabling the infrastructure that drives modern life. Today, we...